Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App





Chest X-Rays Can Aid in Rapid Diagnosis of COVID-19, Find Radiologists

By HospiMedica International staff writers
Posted on 04 Sep 2020
A team of radiologists investigating the usefulness of chest X-rays in COVID-19 have found they could aid in a rapid diagnosis of the disease, especially in areas with limited testing capacity or delayed test results.

Radiologists from the LSU Health Sciences Center New Orleans (New Orleans, LA, USA) conducted a retrospective study of nearly 400 persons under investigation (PUI) for COVID-19. More...
They reviewed the patients’ chest X-rays along with concurrent reverse-transcription polymerase chain reaction (RT-PCR) virus tests. Using well-documented COVID-19 imaging patterns, the radiologists categorized each chest X-ray as characteristic, nonspecific, or negative in appearance for COVID-19. The radiologists found a characteristic chest X-ray appearance is highly specific (96.6%) and has a high positive predictive value of 83.8% for SARS-CoV-2 infection in the setting of pandemic.

“The presence of patchy and/or confluent, band-like ground glass opacity or consolidation in a peripheral and mid-to-lower lung zone distribution on a chest radiograph is highly suggestive of SARS-CoV-2 infection and should be used in conjunction with clinical judgment to make a diagnosis,” said Bradley Spieler MD, Associate Professor of Diagnostic Radiology and Vice Chairman of Research in the Department of Radiology at LSU Health New Orleans School of Medicine.

“The chest radiograph, while low in sensitivity, can indicate COVID-19 in patients whose radiographs exhibit characteristic COVID-19 findings, when used in concert with clinical factors,” said John-Paul Grenier, MD, an LSU Health New Orleans Radiology Resident. “While not a substitute for RT-PCR virus tests or chest CT, radiographs could provide a rapid, cost-effective diagnosis of COVID-19 in a subset of infected patients during the COVID-19 pandemic. The utility of this technique is described in the context of known disadvantages of RT-PCR, considered the gold standard in COVID-19 diagnosis, and Chest CT, which is currently not recommended for COVID-19 diagnosis.”

Related Links:
LSU Health Sciences Center New Orleans


Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Infant Incubator
OKM 801
Critical Care Conversion Kit
Adapter+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.